trog stalwart professor bryan burmeister is retiring from his position at princess alexandra hospital (pah) in brisbane. the highly respected radiation oncologist has worked in various positions with queensland health for 29 years. he has been at pah for the past 16 years. profe...

with every millimetre counting in radiation therapy treatment, a new world first study developed in australia could eventually benefit cancer patients across the world. a new trog study called 'liver ablative radiotherapy with kim' or td 17.03 lark has received $583,000 from the ca...

a new study investigating the use of cutting-edge stereotactic ablative _ radiotherapy (sabr) to treat patients with inoperable kidney cancer has been received $589,000 in funding from cancer australia. trog researcher, a/prof shankar siva, from the university of melbourne and the ...

figure>img alt="file 20180117 53310 9zjg6j.jpg?ixlib=rb 1.1" src="https://images.theconversation.com/files/202371/original/file-20180117-53310-9zjg6j.jpg?ixlib=rb-1.1.0&q=45&auto=format&w=754&fit=clip" /> figcaption>a liquid biopsy is far less invasive than a standard biopsy, where a...

fabulous food was the highlight of the recent trog trek fundraising dinner, with apprentice chefs from the kurri kurri tafe cooking up a feast of culinary delights. the students put all their learnings to the test to come up with a spectacular three course gourmet meal. the even...

a new international trial, which will examine whether the addition of a new type of targeted radiation treatment is more effective for patients with advanced lung, breast or prostate cancer, is now up and running in australia. trog cancer research will lead the trial in australia c...

trog cancer research is pleased to announce the appointment of john cleary to its board. ceo joan torony said that john was a perfect fit for trog’s board as he has more than 20 years’ experience at a senior management and executive level in both the not-for-profit and for-profit indu...

more than 65 people showed their support for cancer research by attending a high tea fundraising event hosted by trog cancer research. the event was held in newcastle, where the trog cancer research has its headquarters. on top of a delicious high tea, guests also took part in a silen...

westmead hospital is now home to a world-first prostate cancer trial, using revolutionary technology to dramatically slash treatment times.  trog's spark trial is underway in several nsw hospitals. it uses an australian-developed technology called kilovoltage intrafraction monitori...

p style="text-align: center;">_ src="/sitefiles/trogcomau/julie_with_mask.jpg" style="height: 338px; width: 600px;" /> trog cancer research is excited to announce julie mccrossin, well-known and respected broadcaster, journalist and former tv host, as its new ambassador. julie has ...

alex carmichael has always been a busy man. during his career he was an executive working for many major australian companies. he's also served as a director of public companies and on the board of many government organisations. he's always been interested in building a better society...

margaret and narelle first met when they were in year four at primary school. the pair have stayed friends since this time and now they are embarking on a trip of a life-time - trekking the wilds of tasmania, raising vital funds for cancer research. margaret and narelle have decide...

patients with advanced skin cancer can now be spared from having to undergo chemotherapy, with results from a new australian study showing that surgery combined with radiotherapy is a more effective treatment. professor sandro porceddu who headed the trog cancer research ‘post’ tri...

in a brain cancer breakthrough, an international clinical trial , has found that adding temozolomide chemotherapy during short-course radiation therapy, followed by monthly maintenance doses of temozolomide, significantly improved survival of elderly patients with glioblastoma (gbm), ...

in a world-first breakthrough for early stage low-grade lymphoma, set to change the management of the disease worldwide, an international clinical trial has found that patients live longer when immuno-chemotherapy is combined with radiotherapy. the results of the international phas...